Most cited papers in Drug-Induced Hepatotoxicity and Protection
What are the most cited papers in Drug-Induced Hepatotoxicity and Protection?
The most cited paper in Drug-Induced Hepatotoxicity and Protection is "Apoptosis by Death Factor" (Shigekazu Nagata, 1997), with 5,008 citations. Next come "The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety" (3,903) and "Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis" (3,348).
Showing 50 of 99 papers. Every paper with more than 762 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Apoptosis by Death Factor Shigekazu Nagata · Cell | Feb 1997 | 5,008 |
| 2 | The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety Martins Ekor · Frontiers in Pharmacology | 2014 | 3,903 |
| 3 | Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis Arun Jayant Sanyal, Naga Chalasani, Kris V. Kowdley et al. · New England Journal of Medicine | 28 Apr 2010 | 3,348 |
| 4 | Bromobenzene-Induced Liver Necrosis. Protective Role of Glutathione and Evidence for 3,4-Bromobenzene Oxide as the Hepatotoxic Metabolite David J. Jollow, John R.D. Mitchell, NICOLA G. ZAMPAGLIONE et al. · Pharmacology | 28 May 2008 | 3,308 |
| 5 | Adverse drug reactions: definitions, diagnosis, and management Ivor Ralph Edwards, Jeffrey K Aronson · The Lancet | Oct 2000 | 3,019 |
| 6 | Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States George Ostapowicz, Robert J. Fontana, Frank Vinholt Schiødt et al. · Annals of Internal Medicine | 17 Dec 2002 | 2,250 |
| 7 | Global burden of liver disease: 2023 update Harshad C. Devarbhavi, Sumeet K. Asrani, Juan Pablo Arab et al. · Journal of Hepatology | 27 Mar 2023 | 2,212 |
| 8 | Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression Peter M. Kuehl, Jiong Zhang, Yvonne Lin et al. · Nature Genetics | Apr 2001 | 2,173 |
| 9 | Early indicators of prognosis in fulminant hepatic failure John G. O'Grady, Graeme J M Alexander, Karen M. Hayllar et al. · Gastroenterology | Aug 1989 | 2,116 |
| 10 | Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver Hendrik Vilstrup, Piero Amodio, Jasmohan Singh Bajaj et al. · Hepatology | 8 Jul 2014 | 2,087 |
| 11 | Acetaminophen‐induced acute liver failure Anne M. Larson, Julie Polson, Robert J. Fontana et al. · Hepatology | 29 Nov 2005 | 1,938 |
| 12 | The Role of Oxidative Stress and Antioxidants in Liver Diseases Sha Li, Hor‐Yue Tan, Ning Wang et al. · International Journal of Molecular Sciences | 2 Nov 2015 | 1,847 |
| 13 | Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model Lutz W. D. Weber, Meinrad Boll, Andreas Stampfl · Critical Reviews in Toxicology | 2003 | 1,783 |
| 14 | ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. IV. PROTECTIVE ROLE OF GLUTATHIONE J.R. Mitchell, David J. Jollow, William Z. Potter et al. · Journal of Pharmacology and Experimental Therapeutics | Oct 1973 | 1,755 |
| 15 | Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis Krishnendu Sinha, Joydeep Das, Pabitra Bikash Pal et al. · Archives of Toxicology | 29 Mar 2013 | 1,644 |
| 16 | Drug-Induced Hepatotoxicity William M. Lee · New England Journal of Medicine | 30 Jul 2003 | 1,586 |
| 17 | Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014 Shiv Kumar Sarin et al. · Hepatology International | 25 Sep 2014 | 1,500 |
| 18 | Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries Gaby Danan, Christian Benichou · Journal of Clinical Epidemiology | Nov 1993 | 1,494 |
| 19 | Calcium Dependence of Toxic Cell Death: A Final Common Pathway Francis A.X. Schanne, Agnes B. Kane, Ellora E. Young et al. · Science | 9 Nov 1979 | 1,490 |
| 20 | Gamma-Globulin and Acquired Immunity to Human Malaria Sydney Cohen, Ian A. McGregor, S.P Carrington · Nature | 25 Nov 1961 | 1,420 |
| 21 | Medicinal plants in therapy Norman R. Farnsworth, Olayiwola Akerele, Audrey S. Bingel · Journal of Ethnopharmacology | May 1987 | 1,369 |
| 22 | Lipid peroxides and human diseases Kunio Yagi · Chemistry and Physics of Lipids | Nov 1987 | 1,327 |
| 23 | Mechanisms of Hepatotoxicity Hartmut Jaeschke · Toxicological Sciences | Feb 2002 | 1,307 |
| 24 | The current state of serum biomarkers of hepatotoxicity Josef S. Ozer, Marcia Hillary Ratner, Martin L Shaw et al. · Toxicology | 6 Dec 2007 | 1,273 |
| 25 | Mechanisms of carbon tetrachloride toxicity Richard O. Recknagel, Eric A. Glende, James A. Dolak et al. · Pharmacology & Therapeutics | 1989 | 1,238 |
| 26 | Oxidative stress as a crucial factor in liver diseases Halina Cichoż‐Lach · World Journal of Gastroenterology | 2014 | 1,230 |
| 27 | ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. II. ROLE OF COVALENT BINDING IN VIVO David J. Jollow, John R.D. Mitchell, William Z. Potter et al. · Journal of Pharmacology and Experimental Therapeutics | Oct 1973 | 1,207 |
| 28 | Acute Liver Failure William E. Bernal, Julia Alexis Wendon · New England Journal of Medicine | 25 Dec 2013 | 1,177 |
| 29 | FUNCTION AND REGULATION OF RAS Douglas R. Lowy, Berthe M. Willumsen · Annual Review of Biochemistry | Jun 1993 | 1,165 |
| 30 | A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug. Paul B. Lazarow, C. De Duve · Proceedings of the National Academy of Sciences | Jun 1976 | 1,146 |
| 31 | Efficacy of Oral N-Acetylcysteine in the Treatment of Acetaminophen Overdose Martin J. Smilkstein, Gary L. Knapp, Kenneth W. Kulig et al. · New England Journal of Medicine | 15 Dec 1988 | 1,123 |
| 32 | Acetaminophen-Induced Hepatic Necrosis David J. Jollow, S S Thorgeirsson, William Z. Potter et al. · Pharmacology | 28 May 2008 | 1,093 |
| 33 | A T cell-dependent experimental liver injury in mice inducible by concanavalin A. Gisa Tiegs, Julia Hentschel, Albrecht Wendel · Journal of Clinical Investigation | Jul 1992 | 1,088 |
| 34 | COVID-19: Abnormal liver function tests Qingxian Cai, Deliang Huang, Hong Yu et al. · Journal of Hepatology | 13 Apr 2020 | 1,086 |
| 35 | N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. David C. Dahlin, Gerald T. Miwa, Albert Lu et al. · Proceedings of the National Academy of Sciences | Mar 1984 | 1,083 |
| 36 | Drug-Related Hepatotoxicity Victor J. Navarro, John R. Senior · New England Journal of Medicine | 15 Feb 2006 | 1,068 |
| 37 | Idiosyncratic drug hepatotoxicity Neil Kaplowitz · Nature Reviews Drug Discovery | Jun 2005 | 1,065 |
| 38 | HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin for the DILIGEN study, Ann K. Daly, Peter T. Donaldson et al. · Nature Genetics | 31 May 2009 | 1,057 |
| 39 | Case Definition and Phenotype Standardization in Drug-Induced Liver Injury Guruprasad Padur Aithal, PB Watkins, Raúl J. Andrade et al. · Clinical Pharmacology & Therapeutics | 4 May 2011 | 1,040 |
| 40 | ACETAMINOPHEN-INDUCED HEPATOTOXICITY Laura Phillips James, Philip R. Mayeux, Jack Hinson · Drug Metabolism and Disposition | 18 Nov 2003 | 1,037 |
| 41 | Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period Raúl J. Andrade, M. Isabel Lucena, M. Carmen Fernández‐Santaella et al. · Gastroenterology | Aug 2005 | 1,020 |
| 42 | Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics Martin Schulz, Stefanie Iwersen‐Bergmann, Hilke Andresen et al. · Critical Care | 26 Jul 2012 | 1,011 |
| 43 | Genetic contribution to variable human CYP3A-mediated metabolism Jatinder Kaur Lamba, Yvonne S. Lin, Erin G. Schuetz et al. · Advanced Drug Delivery Reviews | 28 Oct 2002 | 997 |
| 44 | Mechanisms of Acetaminophen-Induced Liver Necrosis Jack Hinson, Dean W. Roberts, Laura Phillips James · Handbook of experimental pharmacology | 21 Sep 2009 | 994 |
| 45 | AASLD position paper Julie Polson, William M. Lee · Hepatology | 19 Apr 2005 | 989 |
| 46 | Acute liver failure: redefining the syndromes R. B. Williams, Solko Walle Schalm, John G. O’Grady · The Lancet | Jul 1993 | 973 |
| 47 | Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: Lessons learned from acetaminophen hepatotoxicity Hartmut Jaeschke, Mitchell R. McGill, Anup Ramachandran · Drug Metabolism Reviews | 10 Jan 2012 | 963 |
| 48 | Hepatotoxicity Associated With Antiretroviral Therapy in Adults Infected With Human Immunodeficiency Virus and the Role of Hepatitis C or B Virus Infection Mark Sulkowski · JAMA | 5 Jan 2000 | 960 |
| 49 | NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice Alexander Wree, Akiko E. Eguchi, Matthew D. McGeough et al. · Hepatology | 28 Jun 2013 | 953 |
| 50 | The Human Hepatic Cytochromes P450 Involved in Drug Metabolism Steven A. Wrighton, Jeffrey C. Stevens · Critical Reviews in Toxicology | 1992 | 948 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.